Hyperbilirubinemia in pazopanibor sunitinib-treated patients in COMPARZ is associated with UGT1A1 polymorphisms Journal Article


Authors: Motzer, R. J.; Johnson, T.; Choueiri, T. K.; Deen, K. C.; Xue, Z.; Pandite, L. N.; Carpenter, C.; Xu, C. F.
Article Title: Hyperbilirubinemia in pazopanibor sunitinib-treated patients in COMPARZ is associated with UGT1A1 polymorphisms
Journal Title: Annals of Oncology
Volume: 24
Issue: 11
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2013-11-01
Start Page: 2927
End Page: 2928
Language: English
DOI: 10.1093/annonc/mdt394
PROVIDER: scopus
PUBMED: 24107802
PMCID: PMC6394110
DOI/URL:
Notes: --- - "Export Date: 2 December 2013" - "Art. No.: mdt394" - "CODEN: ANONE" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Robert Motzer
    1243 Motzer